MCL1 and pancreatic neoplasm: After treating the BxPC-3 cells for 24 h with Trichostatin A, immunoprecipitation and Western blot results indicated that TSA also promoted Mcl-1 ubiquitination (Fig 2C) and decreased Mcl-1 protein levels in pancreatic cancer cells (Fig 2D).